23 October 2014
Ally Hirschlag Tester Ally Hirschlag is an award-winning journalist with over 10 years of experience editing and writing health, fitness, beauty, lifestyle, and science content
Approved GLP-1 Agonists for Weight Loss Currently, there are two GLP-1R agonists approved for the treatment of obesity, Saxenda (liraglutide) and Wegovy (semaglutide) , both developed by Novo Nordisk and approved by the FDA in 2014 and 2021, respectively
In 2024, the World Anti-Doping Agency (WADA) added GLP-1s to its monitoring list, signaling that officials are paying close attention to how the drugs are being used in sports
For instance, Ozempic usually peaks 24 to 72 hours after injection, while Mounjaro peaks between 8 and 72 hours